Physician profile
Dawood Darbar
NPI 1063596187
$22,299.50
in general payments reported to CMS, 2019-2025
10 companies · $9,780 in 2025
The $9,780 reported for 2025 was more than what 94% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $287 · 2021: $48.09 · 2022: $298 · 2023: $176 · 2024: $237 · 2025: $9,780.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,150 · Consulting Fee: $1,875 · Food and Beverage: $1,117 · Travel and Lodging: $50.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,150.00 |
| Consulting Fee | $1,875.00 |
| Food and Beverage | $1,116.73 |
| Travel and Lodging | $50.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $11,665.17 | 2019-2025 | |
| Ge Healthcare | $7,150.00 | 2025 | |
| Altathera Pharmaceuticals LLC | $1,986.02 | 2025 | Sotalol Hydrochloride |
| Medtronic, INC. | $676.19 | 2022-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $276.03 | 2022-2025 | Resonate El Icd Vr, Watchman Access System, Farapulse |
| Medtronic Vascular, INC. | $236.44 | 2019-2020 | |
| Cardiovascular Systems INC. | $129.27 | 2020 | |
| Cardiva Medical, INC. | $101.30 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Abbott Laboratories | $48.09 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $30.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawood Darbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.